Reported Tuberculosis in the United States, 2010
(PDF - 285k)
Table 44. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom Therapy Was Indicated for One Year or Less: Reporting Areas, 2004–20081
Reporting Area | Year | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2004 | 2005 | 2006 | 2007 | 2008 | ||||||
No.2 | (%)3 | No.2 | (%)3 | No.2 | (%)3 | No.2 | (%)3 | No.2 | (%)3 | |
United States |
12776 |
(83.7) |
12345 |
(83.2) |
12032 |
(83.9) |
11751 |
(84.5) |
11371 |
(84.6) |
Alabama |
179 |
(89.9) |
194 |
(89.7) |
166 |
(86.7) |
149 |
(91.9) |
150 |
(90.0) |
Alaska |
38 |
(84.2) |
57 |
(93.0) |
63 |
(88.9) |
43 |
(88.4) |
45 |
(88.9) |
Arizona |
246 |
(74.8) |
245 |
(83.7) |
273 |
(76.9) |
242 |
(69.4) |
195 |
(72.8) |
Arkansas |
115 |
(88.7) |
103 |
... |
90 |
(90.0) |
96 |
(92.7) |
75 |
(76.0) |
California |
2638 |
(81.8) |
2541 |
(81.3) |
2399 |
(80.9) |
2427 |
(78.9) |
2390 |
(83.1) |
Colorado |
116 |
(96.6) |
85 |
(96.5) |
108 |
(88.9) |
91 |
(97.8) |
94 |
(92.6) |
Connecticut |
85 |
(77.6) |
87 |
(83.9) |
77 |
(88.3) |
96 |
(82.3) |
88 |
(90.9) |
Delaware |
29 |
(93.1) |
24 |
(87.5) |
24 |
(83.3) |
18 |
(94.4) |
22 |
(81.8) |
District of Columbia |
66 |
(93.9) |
49 |
(87.8) |
64 |
(70.3) |
51 |
(70.6) |
49 |
(79.6) |
Florida |
928 |
(85.9) |
968 |
(88.6) |
919 |
(89.4) |
884 |
(90.2) |
826 |
(89.6) |
Georgia |
457 |
(83.6) |
449 |
(82.0) |
443 |
(82.6) |
418 |
(85.2) |
411 |
(86.1) |
Hawaii |
107 |
(80.4) |
95 |
(74.7) |
101 |
(79.2) |
109 |
(76.1) |
115 |
(76.5) |
Idaho |
10 |
(80.0) |
21 |
(76.2) |
18 |
(77.8) |
8 |
(75.0) |
11 |
(90.9) |
Illinois |
503 |
(79.9) |
524 |
(80.0) |
500 |
(82.2) |
456 |
(82.7) |
414 |
(84.5) |
Indiana |
111 |
(93.7) |
133 |
(91.0) |
116 |
(90.5) |
118 |
(89.0) |
102 |
(91.2) |
Iowa |
47 |
(76.6) |
52 |
(84.6) |
37 |
(86.5) |
36 |
(88.9) |
47 |
(89.4) |
Kansas |
57 |
(84.2) |
57 |
(86.0) |
73 |
(93.2) |
53 |
(83.0) |
54 |
(92.6) |
Kentucky |
110 |
(87.3) |
104 |
(87.5) |
75 |
(82.7) |
108 |
(89.8) |
88 |
(80.7) |
Louisiana |
231 |
(73.2) |
218 |
... |
178 |
(77.0) |
196 |
(79.6) |
210 |
(79.5) |
Maine |
18 |
(66.7) |
16 |
(75.0) |
13 |
(100.0) |
18 |
(88.9) |
8 |
... |
Maryland |
279 |
(90.7) |
249 |
(89.2) |
226 |
(90.7) |
246 |
(89.4) |
248 |
(89.1) |
Massachusetts |
256 |
(77.7) |
235 |
(78.7) |
239 |
(85.8) |
205 |
(81.5) |
235 |
(80.9) |
Michigan |
239 |
(87.0) |
201 |
(80.1) |
200 |
(79.5) |
184 |
(82.1) |
151 |
(80.1) |
Minnesota |
188 |
(91.0) |
183 |
(92.9) |
200 |
(90.0) |
225 |
(88.9) |
182 |
(89.6) |
Mississippi |
101 |
(85.1) |
84 |
(84.5) |
97 |
(85.6) |
118 |
(95.8) |
96 |
(92.7) |
Missouri |
111 |
(82.0) |
91 |
(85.7) |
92 |
(76.1) |
106 |
(75.5) |
100 |
(86.0) |
Montana |
14 |
(92.9) |
8 |
(87.5) |
10 |
(90.0) |
11 |
(100.0) |
5 |
(100.0) |
Nebraska |
37 |
(86.5) |
29 |
(75.9) |
23 |
(100.0) |
24 |
(91.7) |
30 |
(80.0) |
Nevada |
88 |
(90.9) |
106 |
... |
82 |
(90.2) |
82 |
(86.6) |
89 |
(83.1) |
New Hampshire |
21 |
(100.0) |
4 |
(75.0) |
15 |
(93.3) |
10 |
(90.0) |
17 |
(82.4) |
New Jersey |
429 |
(82.3) |
423 |
(86.5) |
463 |
(84.9) |
411 |
(85.2) |
379 |
(87.6) |
New Mexico |
33 |
(84.8) |
26 |
(80.8) |
37 |
(81.1) |
43 |
(88.4) |
48 |
(91.7) |
New York State4 |
293 |
(86.3) |
266 |
(87.6) |
271 |
(85.6) |
228 |
(87.3) |
275 |
(85.8) |
New York City |
901 |
(84.5) |
844 |
(82.0) |
823 |
(84.4) |
791 |
(90.8) |
788 |
(88.1) |
North Carolina |
332 |
(92.8) |
290 |
(85.9) |
338 |
(87.3) |
312 |
(91.7) |
301 |
(90.0) |
North Dakota |
4 |
(100.0) |
6 |
(50.0) |
10 |
(60.0) |
4 |
(100.0) |
3 |
(33.3) |
Ohio |
190 |
(87.9) |
231 |
(87.0) |
205 |
(82.9) |
221 |
(87.3) |
189 |
(85.7) |
Oklahoma |
164 |
(80.5) |
118 |
(85.6) |
129 |
(81.4) |
131 |
(81.7) |
86 |
(76.7) |
Oregon |
97 |
(89.7) |
95 |
(93.7) |
71 |
(91.5) |
88 |
(90.9) |
70 |
(97.1) |
Pennsylvania |
280 |
... |
270 |
... |
295 |
(81.7) |
245 |
(82.0) |
343 |
(77.3) |
Rhode Island |
49 |
(85.7) |
41 |
(82.9) |
24 |
(79.2) |
40 |
(90.0) |
34 |
(85.3) |
South Carolina |
213 |
(82.2) |
231 |
(87.4) |
194 |
(86.1) |
188 |
(89.4) |
160 |
(85.0) |
South Dakota |
9 |
(44.4) |
13 |
(53.8) |
12 |
(50.0) |
11 |
(100.0) |
15 |
(93.3) |
Tennessee |
237 |
(86.1) |
267 |
(88.8) |
239 |
(88.3) |
202 |
(86.6) |
248 |
(86.7) |
Texas |
1449 |
(83.0) |
1342 |
(82.3) |
1363 |
(83.1) |
1339 |
(82.0) |
1304 |
(80.4) |
Utah |
32 |
(96.9) |
26 |
(96.2) |
32 |
(84.4) |
35 |
(94.3) |
23 |
(95.7) |
Vermont |
6 |
(66.7) |
7 |
(100.0) |
6 |
(83.3) |
3 |
(33.3) |
5 |
(60.0) |
Virginia |
292 |
(88.4) |
321 |
(83.2) |
292 |
(85.3) |
292 |
(88.4) |
269 |
(83.6) |
Washington |
226 |
(88.5) |
227 |
(83.3) |
227 |
(81.9) |
264 |
(88.6) |
197 |
(90.4) |
West Virginia |
21 |
(81.0) |
24 |
(58.3) |
18 |
(77.8) |
16 |
(100.0) |
22 |
(95.5) |
Wisconsin |
89 |
(79.8) |
65 |
(84.6) |
58 |
(86.2) |
57 |
(77.2) |
60 |
(70.0) |
Wyoming |
5 |
(100.0) |
0 |
... |
4 |
(100.0) |
2 |
(50.0) |
5 |
(80.0) |
American Samoa5 |
3 |
... |
5 |
... |
2 |
(100.0) |
3 |
... |
3 |
... |
Fed. States of Micronesia5 |
7 |
... |
71 |
... |
76 |
... |
126 |
... |
157 |
... |
Guam5 |
45 |
(84.4) |
58 |
(79.3) |
52 |
(86.5) |
90 |
(91.1) |
84 |
(92.9) |
Marshall Islands5 |
38 |
... |
63 |
... |
33 |
... |
124 |
... |
115 |
(80.0) |
N. Mariana Islands5 |
54 |
(87.0) |
54 |
... |
44 |
... |
38 |
(84.2) |
34 |
(70.6) |
Puerto Rico5 |
89 |
(79.8) |
86 |
(87.2) |
89 |
(96.6) |
81 |
(97.5) |
69 |
(95.7) |
Republic of Palau5 |
5 |
(80.0) |
10 |
(100.0) |
9 |
(66.7) |
12 |
... |
14 |
... |
U.S. Virgin Islands5 |
0 |
... |
0 |
... |
0 |
... |
0 |
... |
4 |
(50.0) |
1Most recent year for which data are available.
2Total cases for which therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture.
3Percentage of total cases in persons who completed therapy within one year for whom therapy less than 1 year was indicated.
4Excludes New York City.
5Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Technical Notes for description of Completion of Therapy calculation.